SEC CIK 1222643
ORDONEZ KATHY
Reported ownership across 2 companies, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| PACBview stock → | 403,037 | 2024-06-18 |
| DGXview stock → | 9,569 | 2013-03-31 |
Position History — PACB
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — PACB
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-06-03 | Grant / award (derivative) | 223,492 | $0.00 | 223,492 |
| 2025-06-04 | Grant / award (derivative) | 65,000 | $0.00 | 65,000 |
| 2024-06-18 | Grant / award (derivative) | 32,179 | $0.00 | 32,179 |
| 2024-06-18 | Grant / award | 22,821 | $0.00 | 403,037 |
| 2024-03-15 | Option exercise (derivative) | 37,106 | $0.00 | 0 |
| 2024-03-15 | Option exercise | 324,515 | $2.90 | 343,110 |
| 2024-03-15 | Option exercise | 37,106 | $2.63 | 380,216 |
| 2023-05-24 | Grant / award (derivative) | 25,775 | $0.00 | 25,775 |
| 2022-05-25 | Grant / award (derivative) | 63,015 | $0.00 | 63,015 |
| 2022-02-16 | Open-market sale | 3,280 | $11.50 | 18,595 |
| 2021-06-16 | Grant / award (derivative) | 12,885 | $0.00 | 12,885 |
| 2021-02-16 | Option exercise (derivative) | 50,394 | $0.00 | 37,106 |
| 2021-02-16 | Option exercise (derivative) | 25,485 | $0.00 | 324,515 |
| 2021-02-16 | Option exercise (derivative) | 25,000 | $0.00 | 0 |
| 2021-02-16 | Open-market sale | 118,667 | $47.58 | 123,979 |
| 2021-02-16 | Option exercise | 35,000 | $6.98 | 91,767 |
| 2021-02-16 | Open-market sale | 1,100 | $49.00 | 21,875 |
| 2021-02-16 | Open-market sale | 101,004 | $48.47 | 22,975 |
| 2021-02-16 | Option exercise | 25,000 | $5.79 | 116,767 |
| 2021-02-16 | Option exercise | 50,394 | $2.63 | 242,646 |
| 2021-02-16 | Option exercise | 25,485 | $2.90 | 192,252 |
| 2021-02-16 | Option exercise | 25,000 | $3.81 | 166,767 |
| 2021-02-16 | Option exercise | 25,000 | $8.98 | 141,767 |
| 2020-08-04 | Grant / award (derivative) | 97,785 | $0.00 | 97,785 |
| 2019-02-19 | Open-market sale | 6,933 | $7.17 | 56,767 |
| 2019-02-15 | Grant / award | 19,950 | $0.00 | 63,700 |
| 2018-11-27 | Grant / award (derivative) | 25,000 | $0.00 | 350,000 |
| 2018-11-27 | Open-market sale | 25,000 | $7.54 | 43,750 |
| 2018-11-27 | Option exercise | 25,000 | $2.90 | 68,750 |
| 2018-03-15 | Grant / award (derivative) | 87,500 | $0.00 | 87,500 |
| 2018-03-15 | Grant / award | 43,750 | $0.00 | 43,750 |
| 2017-11-15 | Grant / award (derivative) | 375,000 | $0.00 | 375,000 |
| 2017-05-24 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2016-05-17 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2015-05-20 | Grant / award (derivative) | 25,000 | $0.00 | 25,000 |
| 2014-12-17 | Grant / award (derivative) | 35,000 | $0.00 | 35,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.